Past, present, and future challenges in breast cancer treatment

J Clin Oncol. 2014 Jul 1;32(19):1979-86. doi: 10.1200/JCO.2014.55.4139. Epub 2014 Jun 2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / prevention & control
  • Breast Neoplasms / radiotherapy
  • Breast Neoplasms / surgery
  • Breast Neoplasms / therapy*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Gene Expression Profiling*
  • Genetic Testing
  • Humans
  • Lymph Node Excision / methods
  • Mastectomy / methods*
  • Molecular Targeted Therapy* / methods
  • Mutation
  • Neoadjuvant Therapy / methods*
  • Primary Prevention / methods
  • Randomized Controlled Trials as Topic
  • Receptor, ErbB-2 / analysis
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Risk Reduction Behavior*
  • Sentinel Lymph Node Biopsy
  • Triple Negative Breast Neoplasms / therapy

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor
  • Receptors, Estrogen
  • Receptors, Progesterone
  • ERBB2 protein, human
  • Receptor, ErbB-2